Natasha Zacher, MD
NPI 1083173215 · Dermatology Physician · Medford, OR
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1083173215
- Entity type
- Individual
- Primary specialty
- Dermatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Female
- Sole proprietor
- No
- License
- MD219424 (OR)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
7 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
3 documented practice locations
- Medicare service volume (vs. specialty peers)25% of score
1,769 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Pathology Examination of Tissue Using a Microscope, Intermediate Complexity88305 | 676 | $69 |
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 326 | $7 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 139 | $89 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 102 | $49 |
| Biopsy of Related Skin Growth, First Growth11102 | 78 | $88 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 8 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Hydrocortisone | 53 | 37 |
| Fluorouracil | 44 | 42 |
| Ketoconazole | 38 | 31 |
| Triamcinolone Acetonide | 37 | 24 |
| Fluocinonide | 22 | 21 |
| Clobetasol Propionate | 21 | 17 |
| Valacyclovir Hclbrand: Valacyclovir | 12 | 12 |
| Gabapentin | 12 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$1,988 across 16 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Additional practice locations (2)
- 450 Broadway St # F2Redwood City, CA 94063-3132Phone: (650) 723-6316
- 1719 E 19th AveDenver, CO 80218-1281Phone: (303) 869-2278Fax: (866) 501-9803
Registry dates
- Enumerated
- 2019-03-18
- Last updated
- 2024-10-11
- Certified
- 2024-10-11
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.